Results 101 to 110 of about 12,698 (210)

A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease

open access: yes, 1999
Objective: To compare the long-term efficacy and safety of ropinirole with bromocriptine over 3 years in patients with early PD with Limited or no previous dopaminergic therapy.
Brunt, ER   +4 more
core   +1 more source

A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea

open access: yes, 1994
Cabergoline is a long-acting dopamine-agonist drug that suppresses prolactin secretion and restores gonadal function in women with hyperprolactinemic amenorrhea.
Ferrari, I.   +14 more
core   +1 more source

The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.

open access: yes, 2016
Some patients with hyperprolactinaemia are unable to tolerate even low doses of oral bromocriptine. In such cases, it is difficult to predict whether serum prolactin might be normalized if higher doses could be tolerated, or whether true resistance to ...

core  

BROMOCRIPTINE FOR VISUAL FIELD DEFECTS IN PROLACTINOMAS

open access: yes, 2014
The introduction of bromocriptine (2-brocergocryptine mesylate), a semi-synthetic ergot alkaloid, has revolutionised the treatment of the amenorrhoeagalactorrhoea syndrome due ...
Mustaffa Embong
core  

Effect of bromocriptine therapy in pituitary adenoma an empty sella' appearance

open access: yes, 2005
Prolactin-secreting pituitary adenomas are the most common type of functional pituitary tumor. Bromocriptine therapy is an effective alternative to surgery in this group of patients.
Gupta, AK   +4 more
core  

Case Report: Paralytic ileus as an early manifestation of evolving neuroleptic malignant syndrome in a patient receiving anti-psychotics. [PDF]

open access: yesFront Med (Lausanne)
Arivalagan B   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy